This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Asthma  • Allergy  • Alert me on articles by topic

Prescott G. Woodruff, MD,MPH; John V. Fahy, MD

JAMA. 2001;286:395-398.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Increasing Prevalence of Asthma

The prevalence of asthma has increased sharply in the United States and around the world in the past 30 years. In the United States, data from the National Health Interview Survey show that the annual prevalence of asthma increased from 3.1% in 1980 to 5.4% in 1994.¹ A review of studies performed in 17 countries during the 1960s and repeated in the 1990s confirms an international increase in asthma prevalence.² Although the increasing prevalence of asthma is a global phenomenon, the scope of the problem differs greatly among countries. The International Study of Asthma and Allergies in Childhood, which examined the prevalence of asthma in 56 different countries in the 1990s, found that prevalence ranged from 2% to 3% in Eastern Europe, Indonesia, Greece, Uzbekistan, India, and Ethiopia to 20% in the United Kingdom, Australia, and New Zealand.³ The finding that affluent . . . [Full Text of this Article]

Current Concepts of Asthma Pathogenesis

Causes of Increased Asthma Prevalence

Novel Therapeutic Strategies

Conclusion

Author Affiliations: The Cardiovascular Research Institute and the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco.

RELATED ARTICLE

July 25, 2001
JAMA. 2001;286(4):479-480.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects.
Hauns et al.
J Clin Pharmacol 2006;46:1146-1153.
ABSTRACT | FULL TEXT  

Prevalence of work-aggravated symptoms in clinically established asthma
Saarinen et al.
Eur Respir J 2003;22:305-309.
ABSTRACT | FULL TEXT  

Are We Ready for Universal School-Based Asthma Screening?: An Outcomes Evaluation
Yawn et al.
Arch Pediatr Adolesc Med 2002;156:1256-1262.
ABSTRACT | FULL TEXT